Exploring Opioid Prescriber Decision‐Making: A Qualitative Study
Pharmacoepidemiology and Drug Safety · 2026-06 · 35 (6)
DOI: 10.1002/pds.70402 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 29.05.2026. Verfasst von Jamie L Smith und 12 weiteren Autor:innen. Beteiligte Einrichtung: Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Pain Management, Decision Making. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Health and Human Services, U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research.
Abstract (Originalsprache)
Purpose
To explore the opioid decision‐making process of prescribers in primary care, surgery, and subspecialty pain management.
Methods
This was a multistage qualitative‐qualitative study with clinicians involved in opioid prescribing and management from a single healthcare organization with locations in Minnesota, Florida, Arizona, and Wisconsin. Clinicians in this study included physicians, nurse practitioners (NPs), and physician assistants (PAs) practicing in primary care, surgery, or pain medicine. The interview guide was organized in three domains of a conceptual model for opioid use: (1) prescriber characteristics, (2) patient characteristics, and (3) practice environment characteristics. Individual interviews ( N = 20) were performed first, and data were summarized using a rapid template‐based approach. Subsequently, focus groups (FGs) ( N = 4) were conducted with an additional 21 clinicians to confirm and explore interview results. Data from interviews and FGs were analyzed using a common codebook.
Results
Findings were organized as decision factors into the three domains. Factors in the prescriber domain included characteristics such as formal pain management training, as well as factors that influenced knowledge and beliefs (e.g., advice from or observation of supervising clinicians and expert colleagues). Decision factors in the patient domain included patient pain etiology, comorbid medical or mental health conditions, and demographic characteristics. Clinicians' perceptions of these factors, such as viewing older age as having lesser risk for opioid misuse, influenced prescribing decisions. Clinicians also described challenges associated with “legacy patients” whose therapy was previously managed by a different clinician. Primary care clinicians, in particular, expressed difficulties managing post‐surgical or trauma‐related pain after care transition. Relevant decision factors reported by prescribers in the practice environment domain included guidelines and practice oversight. Most participants reported practicing in an environment that promoted conservative opioid use and having access to standardized institutional guidelines that reduced perceived decision‐making burden. Clinicians described how they used prescribing guidelines to help them communicate with patients about opioid use and prescribing decisions.
Conclusions
Intersecting prescriber, patient, and practice environment factors shape opioid analgesic prescribing decisions. Available resources in the practice environment, including peer input and institutional guidelines, may support clinician decision‐making and conversations with patients at the point of care, including in cases where patients have complex histories or personal characteristics that influence decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
- SNG Research, Rochester, Minnesota, USA.
- Division of Epidemiology, Department of Quantitative Health Services, Mayo Clinic, Rochester, Minnesota, USA.
- Center for Drug Evaluation & Research, U.S. Food and Drug Administration, Silver Springs, Maryland, USA.
- Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Jennifer L Ridgeway
Förderung
- U.S. Department of Health and Human Services
- U.S. Food and Drug Administration (FDA)
- Center for Drug Evaluation and Research
Zitieren
APA
Smith, J. L., Jeffery, M. M., Egginton, J. S., Adams, K., Oloyede, S. V., McCoy, J. J., Yost, K. J., Coleman, B., Eggers, S., Shaw, K. H. H., Moncur, M., Hooten, W. M., & Ridgeway, J. L. (2026). Exploring Opioid Prescriber Decision‐Making: A Qualitative Study. Pharmacoepidemiology and Drug Safety, 35(6). https://doi.org/10.1002/pds.70402
Vancouver
Smith JL, Jeffery MM, Egginton JS, Adams K, Oloyede SV, McCoy JJ, et al. Exploring Opioid Prescriber Decision‐Making: A Qualitative Study. Pharmacoepidemiology and Drug Safety. 2026;35(6). doi:10.1002/pds.70402
BibTeX
@article{Smith2026,
author = {Smith, Jamie L and Jeffery, Molly M and Egginton, Jason S and Adams, Kim and Oloyede, Sey V and McCoy, Jessica J and Yost, Kathleen J and Coleman, Blair and Eggers, Sara and Shaw, Katherine Hyatt Hawkins and Moncur, Megan and Hooten, W Michael and Ridgeway, Jennifer L},
title = {Exploring Opioid Prescriber Decision‐Making: A Qualitative Study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {6},
doi = {10.1002/pds.70402}
}
EUVIMED